Colorectal Cancer

Several non-modifiable risk factors, such as race, sex and family history all contribute to the development of early-onset colorectal cancer, according to study results.

Patients with RAS and BRAF wild-type metastatic colorectal cancer appeared to have significantly worse survival outcomes after first-line anti-EGFR-based therapy if they had uncommon molecular alterations of anti-EGFR primary resistance, according to results of an exploratory analysis of the phase 2 VALENTINO trial.

Colorectal cancer patients who initially presented to primary care with no alarming symptoms had to wait longer for a referral to a specialist, according to recent study findings.

Exact Sciences and the Mayo Clinic are partnering to conduct a study on the real-world, clinical impact of Cologuard on colorectal cancer screening, according to a press release

Researchers recently found that changes in diet can improve the quality of life of patients with inflammatory bowel disease.

Recently published studies have demonstrated new developments in colorectal cancer.

Medical Society of Delaware presented the Tilton Award to Nicholas J. Petrelli, MD, FACS.

The presence of high- or low-risk adenomas at screening colonoscopy could help physicians determine how long to make surveillance intervals, according to study results.

BARCELONA, Spain — Circulating tumor DNA detected through liquid biopsy appeared to be an independent prognostic marker for identifying patients with colorectal cancer who are likely to relapse after surgery, according to results of a phase 3 trial presented at European Society for Medical Oncology Congress.

Researchers from Poland developed a risk classification model that could reduce the number of individuals who would be classified as high-risk for colorectal cancer after colonoscopy screening.